688105.SH
Nanjing Vazyme Biotech Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 22.51
−7.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 145.27x
- P/E 2027E
- 80.70x
- P/E 2028E
- 51.88x
- P/S forward
- 3.92x
Trailing multiples
Trailing twelve months
- P/E TTM
- -700.48x
- PEG TTM
- —
- Price / book
- 3.23x
- Price / sales
- 7.97x
- Price / cash flow
- 53.73x
Enterprise value
- Enterprise value
- CNY 11.3B
- EV / sales
- 8.01x
- EV / EBITDA
- 92.96x
- EV / EBIT
- -263.66x
- Market cap
- CNY 11.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026